AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson’s Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting – PRNewswire

AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson’s Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting – PRNewswire
AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting  PRNewswireNORTH CHICAGO, Ill., April 30, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced experts ... read more
Source: Google NewsPublished on 2019-04-30